These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7700251)

  • 1. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids.
    Burton G; Galigniana M; De Lavallaz S; Brachet-Cota AL; Sproviero EM; Ghini AA; Lantos CP; Damasco MC
    Mol Pharmacol; 1995 Mar; 47(3):535-43. PubMed ID: 7700251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of the potent sodium-retaining steroid 11, 19-oxidoprogesterone.
    Galigniana MD; Vicent GP; Piwien-Pilipuk G; Burton G; Lantos CP
    Mol Pharmacol; 2000 Jul; 58(1):58-70. PubMed ID: 10860927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity of 18,19-dihydroxydeoxycorticosterone and 18-hydroxy-19-nor-deoxycorticosterone to aldosterone receptor and their mineralocorticoid activity.
    Okamoto M; Momoi K; Yamano T; Nakamura M; Odaguchi K; Shimizu T; Okada T; Terasawa T
    Biochem Int; 1983 Dec; 7(6):687-94. PubMed ID: 6237653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestogens with antimineralocorticoid activity.
    Losert W; Casals-Stenzel J; Buse M
    Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 19-Oxo-deoxycorticosterone binds to the renal mineralocorticoid receptor and produces sodium retention but not potassium excretion.
    Thomas CJ; Gomez-Sanchez CE; Marver D; Gomez-Sanchez EP
    Endocrinology; 1983 Aug; 113(2):517-22. PubMed ID: 6307643
    [No Abstract]   [Full Text] [Related]  

  • 6. Extinction of mineralocorticoid effects in 19-norprogesterone derivatives: structure-activity relationships.
    Paris J; Botella J; Fournau P; Bonnet P; Thevenot R
    J Pharmacol Exp Ther; 1987 Oct; 243(1):288-91. PubMed ID: 2822901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 21-Hydroxy-6,19-oxidoprogesterone: a novel synthetic steroid with specific antiglucocorticoid properties in the rat.
    Vicent GP; Monteserín MC; Veleiro AS; Burton G; Lantos CP; Galigniana MD
    Mol Pharmacol; 1997 Oct; 52(4):749-53. PubMed ID: 9380039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal gland involvement in the regulation of renal 11beta-hydroxysteroid dehydrogenase 2.
    Zallocchi ML; Matkovic L; Calvo JC; Damasco MC
    J Cell Biochem; 2004 Jun; 92(3):591-602. PubMed ID: 15156570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenalectomy and steroid replacement in a small macropodid marsupial, the quokka (Setonix brachyurus): metabolic and renal effects.
    McDonald IR; Bradshaw SD
    Gen Comp Endocrinol; 1993 Apr; 90(1):64-77. PubMed ID: 8504924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
    Yamakawa M; Ezumi K; Shiro M; Nakai H; Kamata S; Matsui T; Haga N
    Mol Pharmacol; 1986 Dec; 30(6):585-9. PubMed ID: 3023811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid receptors in human kidney.
    Matulich DT; Spindler BJ; Schambelan M; Baxter JD
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1170-4. PubMed ID: 993320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of an essential amino group in the mineralocorticoid receptor evidences a differential conformational change of the receptor protein upon binding of antagonists, natural agonists and the synthetic agonist 11,19-oxidoprogesterone.
    Piwien-Pilipuk G; Kanelakis KC; Ghini AA; Lantos CP; Litwack G; Burton G; Galigniana MD
    Biochim Biophys Acta; 2002 Feb; 1589(1):31-48. PubMed ID: 11909639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative inhibition by hard and soft metal ions of steroid-binding capacity of renal mineralocorticoid receptor cross-linked to the 90-kDa heat-shock protein heterocomplex.
    Galigniana MD; Piwien-Pilipuk G
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):585-92. PubMed ID: 10417321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line.
    Gaeggeler HP; Gonzalez-Rodriguez E; Jaeger NF; Loffing-Cueni D; Norregaard R; Loffing J; Horisberger JD; Rossier BC
    J Am Soc Nephrol; 2005 Apr; 16(4):878-91. PubMed ID: 15743993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of aldosterone receptors in rat kidney: effects of steroid treatment and potassium diet.
    Rafestin-Oblin ME; Claire M; Lombes M; Michaud A; Corvol P
    J Steroid Biochem; 1984 Oct; 21(4):465-70. PubMed ID: 6238210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of transformed steroid compounds on mRNA synthesis and glucocorticoid-receptor interaction in thymocytes of adrenalectomized rats].
    Golikov PP; Bobkova AS; Kamernitskiĭ AV; Reshetova IG
    Farmakol Toksikol; 1982; 45(2):89-93. PubMed ID: 7075758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential recruitment of tetratricorpeptide repeat domain immunophilins to the mineralocorticoid receptor influences both heat-shock protein 90-dependent retrotransport and hormone-dependent transcriptional activity.
    Gallo LI; Ghini AA; Piwien Pilipuk G; Galigniana MD
    Biochemistry; 2007 Dec; 46(49):14044-57. PubMed ID: 18001136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of synthetic progestagens with renal mineralocorticoid receptors.
    Wambach G; Higgins JR; Kem DC; Kaufmann W
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):560-7. PubMed ID: 574701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 19-Nor deoxycorticosterone (19-nor DOC): mineralocorticoid receptor affinity higher than aldosterone, electrolyte activity lower.
    Funder JW; Mercer J; Ingram B; Feldman D; Wynne K; Adam WR
    Endocrinology; 1978 Oct; 103(4):1514-7. PubMed ID: 744165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal action of progesterone and 18-substituted derivatives.
    Rafestin-Oblin ME; Couette B; Barlet-Bas C; Cheval L; Viger A; Doucet A
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F828-32. PubMed ID: 1647687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.